Moreover, the levels of total and activated CD8+ cytotoxic T cells (GzmB+) that infiltrated the tumor microenvironment were significantly increased in the AUY-922 treated group (Supplementary Fig. 7E, F). The gene discussed is CD8A; the disease is neoplasm.